News

Madrigal gets EU nod for its MASH treatment

Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...
Zacks.com on MSN18h

Madrigal Gets Conditional Nod for MASH Drug Rezdiffra in EU

Madrigal Pharmaceuticals MDGL announced that the European Commission (EC) has granted a conditional marketing authorization ...
Pharmabiz4h

Madrigal Pharma’s Rezdiffra gets European Commission’s conditional marketing nod to treat MASH with moderate to advanced liver fibrosis

Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...

Cytokinetics Names Jim Daly to Board of Directors

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors ...